强心汤对慢性心力衰竭大鼠心肌线粒体稳态和能量代谢的影响

庞延; 毛美玲; 卢健棋; 陈佳永; 唐梅玲; 黄溥玮

doi:10.6039/j.issn.1001-0408.2024.15.06

您当前的位置：

首页 >

文章列表页 >

强心汤对慢性心力衰竭大鼠心肌线粒体稳态和能量代谢的影响

药学研究 | 更新时间：2024-08-11

- 强心汤对慢性心力衰竭大鼠心肌线粒体稳态和能量代谢的影响
- Effects of Qiangxin decoction on myocardial mitochondrial homeostasis and energy metabolism in chronic heart failure rats
- 中国药房 2024年35卷第15期页码：1831-1836
- 作者机构：
  
  1.广西中医药大学第一附属医院急诊科，南宁　530001
  2.广西中医药大学研究生院，南宁　530001
  3.广西中医药大学第一附属医院心血管一区，南宁　530001
- 作者简介：
  
  主治医师，博士研究生。研究方向：中西医结合防治心血管病。E-mail：271528495@qq.com
  主任医师，教授，博士生导师。研究方向：中西医结合防治心血管病。E-mail：lujianqi666@163.com
- 基金信息：
  
  广西自然科学基金项目(2021GXNSFBA196018;2021GXNSFAA220111);Δ 基金项目国家自然科学基金资助项目(82160887);国家中医药传承创新中心项目(2023019-10);广西岐黄学者培养项目(2024005-06-02)
- DOI：10.6039/j.issn.1001-0408.2024.15.06
  中图分类号： R285;R256.2
- 纸质出版日期：2024-08-15，
  
  收稿日期：2024-02-29，
  
  修回日期：2024-05-20，
- 稿件说明：
扫描看全文
庞延,毛美玲,卢健棋等.强心汤对慢性心力衰竭大鼠心肌线粒体稳态和能量代谢的影响 ^Δ[J].中国药房,2024,35(15):1831-1836.

PANG Yan,MAO Meiling,LU Jianqi,et al.Effects of Qiangxin decoction on myocardial mitochondrial homeostasis and energy metabolism in chronic heart failure rats[J].ZHONGGUO YAOFANG,2024,35(15):1831-1836.
庞延,毛美玲,卢健棋等.强心汤对慢性心力衰竭大鼠心肌线粒体稳态和能量代谢的影响 ^Δ[J].中国药房,2024,35(15):1831-1836. DOI： 10.6039/j.issn.1001-0408.2024.15.06.

PANG Yan,MAO Meiling,LU Jianqi,et al.Effects of Qiangxin decoction on myocardial mitochondrial homeostasis and energy metabolism in chronic heart failure rats[J].ZHONGGUO YAOFANG,2024,35(15):1831-1836. DOI： 10.6039/j.issn.1001-0408.2024.15.06.

摘要

目的

基于线粒体自噬，探讨强心汤对慢性心力衰竭（CHF）大鼠心肌线粒体稳态和能量代谢的影响。

方法

取雄性SD大鼠，通过结扎左冠状动脉前降支构建CHF模型，并将造模成功的大鼠按随机数字表法分为模型组、强心汤组[12.25 g/（kg·d），按生药量计]、卡托普利组[10.38 mg/（kg·d）]、强心汤+卡托普利组（用法用量同各单药组），每组8只；另取正常大鼠8只，仅于左冠状动脉前降支穿线但不结扎，作为假手术组。从造模成功次日开始，各药物组大鼠每天分2次灌胃相应药液，连续28 d。末次给药后，检测梗死心肌组织中腺苷三磷酸（ATP）、腺苷一磷酸（AMP）、游离脂肪酸（FFA）水平，观察其病理改变和线粒体形态，检测其B细胞淋巴瘤2（Bcl-2）、Bcl-2相关X蛋白（Bax）、TANK结合激酶1（TBK1）、p62蛋白的表达情况。

结果

与假手术组比较，模型组大鼠心肌组织纤维化明显，大量线粒体肿胀、融合，内嵴断裂；梗死心肌组织中AMP、FFA水平和Bax、p62蛋白的表达均显著升高或上调，ATP水平和Bcl-2、TBK1蛋白的表达均显著降低或下调（

＜0.05）。与模型组比较，各药物组大鼠心肌组织病理改变和线粒体肿胀均有所改善，梗死心肌组织中AMP、FFA水平和Bax、p62蛋白的表达均显著降低或下调（

＜0.05），ATP水平和Bcl-2、TBK1蛋白的表达均显著升高或上调（

＜0.05），且强心汤+卡托普利组的效果优于各单药组（

＜0.05）。

结论

强心汤能够减轻CHF大鼠心肌纤维化、线粒体肿胀，改善其心肌能量代谢；上述作用可能与调控Bcl-2、Bax、TBK1、p62蛋白表达，促进心肌线粒体自噬有关。

Abstract

OBJECTIVE

To investigate the effects of Qiangxin decoction on myocardial mitochondrial and energy metabolism in rats with chronic heart failure （CHF） based on mitophagy.

METHODS

Male SD rats were collected to establish CHF model by ligating the left anterior descending branch of coronary artery. The successful modeling rats were divided into model group， Qiangxin decoction group [12.25 g/（kg·d）， calculated by crude drug]， captopril group [10.38 mg/（kg·d）]， and Qiangxin decoction+captopril group （the same usage and dosage as single drug group） according to a random number table method， with 8 rats in each group. Another 8 normal rats were selected and received threading in the left anterior descending branch of the coronary artery without ligation as the sham operation group. Starting from the second day after successful modeling， the rats in administration groups were given relevant drug intragastrically， twice a day， for consecutive 28 days. After the last medication， the levels of adenosine triphosphate （ATP）， adenosine monophosphate （AMP） and free fatty acid （FFA） in infarcted myocardial tissues were detected， the pathological changes and mitochondrial morphology of the infarcted myocardial tissue were observed， as well as the protein expressions of B cell lymphoma-2 （Bcl-2）， Bcl-2 related X protein （Bax）， TANK-binding kinase 1 （TBK1）， p62 were detected in each group.

RESULTS

Compared with the sham operation group， the infarcted myocardial tissue fibrosis was changed evidently， with a large number of mitochondrial swelling and fusion， and internal cristae rupture； the levels of AMP and FFA， the protein expressions of Bax and p62 were all increased or up-regulated significantly in infarcted myocardial tissue， while the level of ATP， and the protein expressions of Bcl-2 and TBK1 were all decreased or down-regulated significantly （

＜0.05）. Compared with the model group， the pathological changes of infarcted myocardial tissue and mitochondrial swelling had been improved； the levels of AMP and FFA， and the protein expressions of Bax and p62 in infarcted myocardial tissue were significantly decreased or down-regulated in administration groups， while the level of ATP， and the protein expressions of Bcl-2 and TBK1 were increased or up-regulated significantly （

＜0.05）. And the effect of Qiangxin decoction+captopril group was better than that of single drug group.

CONCLUSIONS

Qiangxin decoction can alleviate myocardial fibrosis and mitochondrial swelling in CHF rats， and improve their myocardial energy metabolism， which may be related to regulating the expression of Bcl-2， Bax， TBK1 and p62 proteins and promoting myocardial mitophagy.

关键词

强心汤慢性心力衰竭线粒体自噬线粒体稳态能量代谢

Keywords

chronic heart failuremitophagymitochondrial homeostasisenergy metabolism

references

MCDONAGH T A，METRA M，ADAMO M，et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure[J]. Eur Heart J，2021，42（36）：3599-3726.

中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2022概要[J]. 中国循环杂志，2023，38（6）：583-612.

The Writing Committee of the Report on Cardiovascular Health and Disease in China. Report on cardiovascular health and diseases in China 2022：an updated summary[J]. Chin Circ J，2023，38（6）：583-612.

MCDONAGH T A，METRA M，ADAMO M，et al. 2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure[J]. Eur Heart J，2023，44（37）：3627-3639.

中华中医药学会慢性心力衰竭中医诊疗指南项目组. 慢性心力衰竭中医诊疗指南：2022年[J]. 中医杂志，2023，64（7）：743-756.

Project Group of Traditional Chinese Medicine Guideline for Diagnosis and Treatment of Chronic Heart Failure，China Association of Chinese Medicine. Traditional Chinese medicine guideline for diagnosis and treatment of chronic heart failure：2022[J]. J Tradit Chin Med，2023，64（7）：743-756.

高文静，马宏，项美香. 心肌能量底物代谢重构与心力衰竭关系的研究进展[J]. 解放军医学杂志，2021，46（8）：822-826.

GAO W J，MA H，XIANG M X. Research progress on the metabolic remodeling of myocardial energy substrate in heart failure[J]. Med J Chin People’s Liberation Army，2021，46（8）：822-826.

GORĄCY A，ROSIK J，SZOSTAK J，et al. Improving mitochondrial function in preclinical models of heart failure：therapeutic targets for future clinical therapies?[J]. Expert Opin Ther Targets，2023，27（7）：593-608.

TANG Y，XU W，LIU Y，et al. Autophagy protects mitochondrial health in heart failure[J]. Heart Fail Rev，2024，29（1）：113-123.

庞延，林浩，卢健棋，等. 强心汤联合八段锦治疗老年慢性心力衰竭伴衰弱患者的临床疗效[J]. 中国实验方剂学杂志，2023，29（4）：104-109.

PANG Y，LIN H，LU J Q，et al. Clinical efficacy of Qiangxin decoction combined with Baduanjin in treatment of elderly patients with chronic heart failure and weakness[J]. Chin J Exp Tradit Med Formulae，2023，29（4）：104-109.

庞延，卢健棋，唐梅玲，等. 强心汤对慢性心力衰竭模型大鼠梗死心肌区组织活性氧及PINK1/parkin介导的线粒体自噬的影响[J]. 中医杂志，2023，64（7）：722-728.

PANG Y，LU J Q，TANG M L，et al. Effect of Qiangxin decoction on reactive oxygen species and PINK1/parkin mediated mitochondrial autophagy in myocardium of chronic heart failure model rats[J]. J Tradit Chin Med，2023，64（7）：722-728.

周爽，蒋智渊，钟国强. 线粒体自噬与心力衰竭[J]. 中国病理生理杂志，2020，36（5）：924-929，935.

ZHOU S，JIANG Z Y，ZHONG G Q. Mitophagy and heart failure[J]. Chin J Pathophysiol，2020，36（5）：924-929，935.

MARCHI S，GUILBAUD E，TAIT S W G，et al. Mitochondrial control of inflammation[J]. Nat Rev Immunol，2023，23（3）：159-173.

朱智德，庞延，卢健棋，等. 强心汤对慢性心力衰竭模型大鼠心肌组织OMA1、OPA1表达及线粒体形态的影响[J]. 中医杂志，2021，62（3）：266-270，276.

ZHU Z D，PANG Y，LU J Q，et al. Effect of Qiangxin decoction on OMA1 and OPA1 expression and mitochondrial morphology of myocardial tissue in chronic heart failure model rats[J]. J Tradit Chin Med，2021，62（3）：266-270，276.

SAVARESE G，BECHER P M，LUND L H，et al. Global burden of heart failure：a comprehensive and updated review of epidemiology[J]. Cardiovasc Res，2023，118（17）：3272-3287.

HEIDENREICH P A，BOZKURT B，AGUILAR D，et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure：a report of the American College of Cardio-logy/American Heart Association Joint Committee on clinical practice guidelines[J]. J Am Coll Cardiol，2022，79（17）：e263-e421.

FAN G，CHEN M J，WEI J. Involvement of phosphatase and tensin homolog-induced putative kinase 1/Parkin-mediated autophagy in angiotensin Ⅱ-induced cardiac hypertrophy in C57BL/6 mice[J]. J Int Med Res，2020，48（5）：300060519896143.

XU H X，CUI S M，ZHANG Y M，et al. Mitochondrial Ca2+ regulation in the etiology of heart failure：physiolo-gical and pathophysiological implications[J]. Acta Pharmacol Sin，2020，41（10）：1301-1309.

SABBAH H N. Targeting the mitochondria in heart fai-lure：a translational perspective[J]. JACC Basic Transl Sci，2020，5（1）：88-106.

BILLINGSLEY H，CANADA J M，MARKLEY R，et al. Abstract P436：the role of free fatty acids in patients with obesity and heart failure with preserved ejection fraction：a post-hoc analysis of the UFA-preserved pilot study[J/OL]. Circulation，2020，141（Suppl. 1）[2024-01-25]. https：// www.researchgate.net/publication/339660476.DOI：10.1161/ circ.141.suppl_1.P436https://www.researchgate.net/publication/339660476.DOI:10.1161/circ.141.suppl_1.P436.

熊永红，陶洁，田浩，等. TBK1过表达对小鼠高糖离体心肌细胞缺氧复氧损伤的影响：与线粒体自噬的关系[J]. 中华麻醉学杂志，2021，41（8）：996-999.

XIONG Y H，TAO J，TIAN H，et al. Effect of TBK1 overexpression on hypoxia-reoxygenation injury in isolated mouse cardiomyocytes subjected to high glucose：relationship with mitochondrial autophagy[J]. Chin J Anesthesiol，2021，41（8）：996-999.

黎燚华，陈琦，康亮，等. 基于网络药理学和分子对接技术探讨人参、丹参、葶苈子治疗慢性心力衰竭的分子机制[J]. 中西医结合心脑血管病杂志，2022，20（21）：3855-3863.

LI Y H，CHEN Q，KANG L，et al. The molecular mechanism of Panax ginseng，Salvia miltiorrhiza，and Descurainiae Semen Lepidii Semen in treating chronic heart failure based on network pharmacology and molecular docking[J]. Chin J Integr Med Cardio Cerebrovasc Dis，2022，20（21）：3855-3863.

李钰鑫，阎美卉，李森. 基于网络药理学与分子对接研究黄芪-附子治疗慢性心力衰竭的机制[J]. 世界中医药，2022，17（16）：2251-2257.

LI Y X，YAN M H，LI S. Mechanism of Astragali Radix-Aconiti Lateralis Radix Preparata in the treatment of chronic heart failure based on network pharmacology and molecular docking[J]. World Chin Med，2022，17（16）：2251-2257.

王文琪，崔磊，张馨方，等. 茯苓桂枝药对对慢性心力衰竭模型大鼠心肌组织血管紧张素Ⅱ受体1及血清炎症因子的影响[J]. 中医杂志，2020，61（21）：1921-1926.

WANG W Q，CUI L，ZHANG X F，et al. Effects of drug-pair of Poria and Guizhi（Ramulus Cinnamomi）on angiotensin Ⅱ receptor 1 and serum inflammatory factors of myocardial tissue in chronic heart failure model rats[J]. J Tradit Chin Med，2020，61（21）：1921-1926.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

槲皮素对心肌缺血后线粒体能量代谢功能的影响

人参-茯苓药对抗衰老活性条件筛选及机制研究

潜在的代谢性疾病治疗靶点孤核受体NR4A的生物学特征及调控机制

黄芩素和汉黄芩素抑制肝癌细胞能量代谢的作用机制差异研究

干姜水煎液对心肌细胞线粒体功能损伤的改善作用研究